V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003814 | 210013628 | 1.72 | 76.8 | null | 2017-06-03 | 2017-07-05 | PERTUZUMAB + TRASTUZUMAB | 02 | null | PERTUZUMAB + TRASTUZUMAB | 100731635 |
| 210003819 | 210013629 | 1.56 | 83.7 | null | 2018-11-04 | 2019-11-05 | Neratinib | null | null | NERATINIB | 100807799 |
| 210003826 | 210013632 | 1.63 | 84 | Adjuvant (A) | 2020-09-14 | 2020-09-15 | Paclitaxel+Trastuzumab wkly Maint | N | N | PACLITAXEL + TRASTUZUMAB | 101339951 |
| 210003844 | 210013636 | 1.61 | 71.5 | Palliative (P) | 2021-10-03 | 2021-10-19 | null | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100348651 |
| 210003845 | 210013637 | 1.76 | 58.6 | Adjuvant (A) | null | 2022-03-21 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100474186 |
| 210003850 | 210013638 | 1.6 | 0 | null | 2020-01-28 | 2020-02-01 | null | 02 | null | ROSCO TRIAL | 100865385 |
| 210003859 | 210013641 | null | null | null | 2022-03-03 | 2022-03-12 | PERTUZUMAB + TRASTUZUMAB | 02 | null | PERTUZUMAB + TRASTUZUMAB | 100934002 |
| 210003864 | 210013643 | 1.67 | 56 | Palliative (P) | 2019-10-27 | 2020-01-27 | Capecitabine | 02 | N | CAPECITABINE | 100309071 |
| 210003870 | 210013644 | 1.57 | 57.5 | Palliative (P) | 2020-01-30 | 2020-05-11 | PERTUZUMAB + TRASTUZUMAB | 01 | null | PERTUZUMAB + TRASTUZUMAB | 101050368 |
| 210003872 | 210013646 | 1.7 | 86 | Palliative (P) | null | 2022-01-24 | Capecitabine | null | N | CAPECITABINE | 100048535 |
| 210003879 | 210013649 | 1.51 | 57 | Neo-adjuvant (N) | 2022-03-08 | 2022-03-23 | Pertuzumab (Maintenance) | 02 | N | PERTUZUMAB | 100017528 |
| 210000062 | 210013651 | 1.71 | 100 | Palliative (P) | 2020-05-17 | 2020-05-18 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | null | N | LETROZOLE + PALBOCICLIB | 100225173 |
| 210001086 | 210013656 | 1.7 | 66.1 | Palliative (P) | 2021-10-10 | 2021-12-29 | GEMCARBO | 02 | null | PALBOCICLIB | 101663547 |
| 210001109 | 210013657 | null | null | null | 2018-07-03 | 2018-09-26 | null | null | null | ALECTINIB | 100904517 |
| 210001120 | 210013658 | 1.75 | 55.4 | null | 2021-02-02 | 2021-05-05 | ABEMACICLIB + FULVESTRANT | 02 | null | EC | 100823922 |
| 210001126 | 210013659 | 1.69 | 80.8 | Curative (C) | 2020-03-05 | 2020-03-18 | Carboplatin AUC 6 - 10 | null | N | CARBOPLATIN | 101674658 |
| 210001184 | 210013660 | null | null | null | 2017-09-10 | 2017-10-20 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100896768 |
| 210001616 | 210013662 | 1.59 | 64.6 | Palliative (P) | 2018-12-21 | 2019-03-04 | FEC + DOCETAXEL | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101284861 |
| 210001833 | 210013663 | 1.63 | 83 | null | 2018-05-08 | 2018-08-20 | null | null | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101799390 |
| 210001876 | 210013664 | 1.57 | 75.95 | Neo-adjuvant (N) | null | 2020-10-24 | Capecitabine | 02 | N | CAPECITABINE | 100936518 |
| 210002038 | 210013666 | 1.58 | 74.5 | null | 2021-06-08 | 2021-06-28 | null | 02 | null | TRIAL UNSPECIFIED | 101316970 |
| 210002107 | 210013668 | 1.61 | 76.5 | Adjuvant (A) | 2019-11-05 | 2019-12-04 | Vinorelbine (oral) | 02 | N | VINORELBINE | 101536240 |
| 210002127 | 210013669 | 1.58 | 101.9 | Neo-adjuvant (N) | 2021-05-12 | 2021-05-31 | null | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100657281 |
| 210002144 | 210013670 | 0 | 110 | null | 2021-10-29 | 2021-10-29 | CARBOPLATIN + DOCETAXEL + Pertuzumab + Trastuzumab | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100163344 |
| 210002229 | 210013671 | null | null | null | 2020-05-14 | 2020-05-27 | null | 02 | null | CARBOPLATIN + GEMCITABINE | 101584469 |
| 210002362 | 210013672 | 1.64 | 95.85 | null | 2021-03-18 | 2021-04-06 | null | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100908757 |
| 210002637 | 210013674 | 1.66 | 87.35 | null | 2021-12-31 | 2022-03-28 | Neratinib | 02 | null | NERATINIB | 101493616 |
| 210002751 | 210013675 | 1.6 | 75.7 | Neo-adjuvant (N) | 2019-07-02 | 2019-07-10 | Palbociclib | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100755182 |
| 210003252 | 210013677 | 1.68 | 69 | Neo-adjuvant (N) | 2022-02-24 | 2022-03-05 | Epirubicin (weekly) | null | N | PACLITAXEL + TRASTUZUMAB | 101129757 |
| 210003466 | 210013679 | 1.73 | 78.3 | null | 2021-09-07 | 2021-12-03 | Everolimus 10mg | 02 | null | FULVESTRANT + PALBOCICLIB | 100042368 |
| 210003473 | 210013680 | null | 60.75 | null | 2021-03-23 | 2021-06-04 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100851270 |
| 210003548 | 210013683 | 1.6 | 111.2 | Adjuvant (A) | 2019-09-11 | 2019-09-23 | null | null | N | FEC | 100525179 |
| 210003879 | 210013685 | 1.7 | 78.3 | null | null | 2021-10-13 | null | 02 | null | CARBOPLATIN + PACLITAXEL | 100017528 |
| 210003568 | 210013688 | null | null | null | 2021-11-15 | 2022-05-07 | Capecitabine | null | null | CAPECITABINE | 100026134 |
| 210003712 | 210013749 | null | null | null | null | 2020-10-21 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 101840371 |
| 210003721 | 210013753 | 1.59 | 88 | Adjuvant (A) | null | 2020-09-04 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100577965 |
| 210003722 | 210013754 | 1.88 | 74.9 | Adjuvant (A) | 2018-10-29 | 2020-03-13 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100420307 |
| 210003723 | 210013755 | 1.62 | 69.2 | null | 2019-11-28 | 2020-04-15 | Docetaxel | 02 | null | DOCETAXEL | 100832036 |
| 210003725 | 210013756 | 1.64 | 61.5 | null | 2017-12-19 | 2018-01-17 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100388097 |
| 210003727 | 210013757 | 1.6 | 81.4 | Adjuvant (A) | 2018-08-12 | 2019-09-20 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101141121 |
| 210003728 | 210013758 | null | null | null | 2018-11-13 | 2019-02-01 | PACLITAXEL | 02 | null | PACLITAXEL | 100605706 |
| 210003736 | 210013760 | 1.67 | 64.5 | Adjuvant (A) | null | 2020-02-22 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101855705 |
| 210003742 | 210013762 | 1.57 | 106 | Neo-adjuvant (N) | 2021-01-03 | 2021-05-05 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 100243128 |
| 210003748 | 210013763 | 1.67 | 77 | Adjuvant (A) | 2017-10-12 | 2017-11-12 | Docetaxel 100mg/m2 (21 day) | 02 | Y | DOCETAXEL | 101091256 |
| 210003749 | 210013764 | 1.68 | 60.5 | Adjuvant (A) | null | 2021-02-11 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101397605 |
| 210003751 | 210013766 | 1.59 | 84.7 | Adjuvant (A) | null | 2021-06-30 | Docetaxel | null | N | DOCETAXEL | 101566613 |
| 210003767 | 210013768 | 1.64 | 101.1 | Adjuvant (A) | 2020-11-15 | 2021-03-10 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100759298 |
| 210003768 | 210013769 | 1.55 | 50.4 | Palliative (P) | null | 2021-04-21 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | PACLITAXEL | 101547987 |
| 210003792 | 210013773 | null | 67 | Adjuvant (A) | 2021-09-27 | 2021-12-15 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100133076 |
| 210003797 | 210013774 | null | 75.4 | Adjuvant (A) | 2022-02-01 | 2022-02-02 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100216251 |